Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter November 28, 2022

Critical appraisal of “choosing which in-hospital laboratory tests to target for intervention: a scoping review”

  • Simona Ferraro EMAIL logo , Cristina Cereda , Gianvincenzo Zuccotti and Elia Mario Biganzoli EMAIL logo

Corresponding authors: Simona Ferraro, Newborn Screening and Genetic Metabolic Diseases Unit, “V. Buzzi” Children’s Hospital, Milan, Italy; and Endocrinology Laboratory Unit, “Luigi Sacco” University Hospital, University of Milan, Milan, Italy, E-mail: ; and Elia Mario Biganzoli, Medical Statistics Unit, Department of Biomedical and Clinical Sciences L. Sacco, “Luigi Sacco” University Hospital, University of Milan, Milan, Italy, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: Not applicable.

References

1. Podolsky, E, Hudek, N, McCudden, C, Presseau, J, Yanikomeroglu, S, Brouwers, M, et al.. Choosing which in-hospital laboratory tests to target for intervention: a scoping review. Clin Chem Lab Med 2022. https://doi.org/10.1515/cclm-2022-0910.Search in Google Scholar PubMed

2. Ferraro, S, Panteghini, M. The role of laboratory in ensuring appropriate test requests. Clin Biochem 2017;50:555–61. https://doi.org/10.1016/j.clinbiochem.2017.03.002.Search in Google Scholar PubMed

3. Ferraro, S, Bussetti, M, Panteghini, M. Serum prostate specific antigen (PSA) testing for early detection of prostate cancer: managing the gap between clinical and laboratory practice. Clin Chem 2021;67:602–9. https://doi.org/10.1093/clinchem/hvab002.Search in Google Scholar PubMed

4. Ferraro, S, Mozzi, R, Panteghini, M. Tumor marker ordering: do not lose control a prospective clinical trial. Am J Clin Pathol 2015;144:649–58. https://doi.org/10.1309/ajcpnzapjrb3t6kk.Search in Google Scholar

5. Ferraro, S, Trevisiol, C, Gion, M, Panteghini, M. Human chorionic Gonadotropin assays for testicular tumors: closing the gap between clinical and laboratory practice. Clin Chem 2018;64:270–8. https://doi.org/10.1373/clinchem.2017.275263.Search in Google Scholar PubMed

6. Ferraro, S, Panzeri, A, Panteghini, M. Tackling serum folate test in European countries within the health technology assessment paradigm: request appropriateness, assays, and health outcomes. Clin Chem Lab Med 2017;55:1262–75. https://doi.org/10.1515/cclm-2016-0804.Search in Google Scholar PubMed

7. Ferraro, S, Biganzoli, EM, Castaldi, S, Plebani, M. Health Technology Assessment to get value from biomarkers in the decision making process. Clin Chem Lab Med 2022;60:647–54. https://doi.org/10.1515/cclm-2021-1291.Search in Google Scholar PubMed

8. Epner, PL, Gans, JE, Graber, ML. When diagnostic testing leads to harm: a new outcomes-based approach for laboratory medicine. BMJ Qual Saf 2013;22:ii6–10. https://doi.org/10.1136/bmjqs-2012-001621.Search in Google Scholar PubMed PubMed Central

Received: 2022-11-15
Accepted: 2022-11-15
Published Online: 2022-11-28
Published in Print: 2023-02-23

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 27.4.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2022-1164/html
Scroll to top button